US · Healthcare

Longduoduo Company Limited (LDDD)

Diagnostics & Research

Longduoduo Company Limited (LDDD) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for LDDD

P/E ratio

18.00

Longduoduo Company Limited (LDDD) — FAQ

What is LDDD's P/E ratio?

The price-to-earnings (P/E) ratio for Longduoduo Company Limited (LDDD) is 18.00 (data as of 2026-03-24).

Does Longduoduo Company Limited pay a dividend?

Dividend yield is not available in the current snapshot for Longduoduo Company Limited (LDDD). Check the MyAverix Finance app for the latest dividend data.

What sector is Longduoduo Company Limited in?

Longduoduo Company Limited (LDDD) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is LDDD listed on?

LDDD is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)